# Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

> **NCT03682302** · PHASE3 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 98 (actual)

## Conditions studied

- Postoperative Pain Management

## Interventions

- **DRUG:** Exparel
- **DRUG:** 0.5% Bupivacaine HCl

## Key facts

- **NCT ID:** NCT03682302
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-02
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-09-24
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2021-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03682302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03682302, "Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03682302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*